AHSCT stands for Autologous Hematopoietic Stem Cell Transplantation. It is a medical procedure used primarily in the treatment of certain cancers, such as multiple myeloma and some types of leukemia and lymphoma. In AHSCT, a patient’s own hematopoietic stem cells—cells that can develop into all types of blood cells—are collected from their blood or bone marrow before they undergo high-dose chemotherapy or radiation therapy. After the aggressive treatment aimed at eradicating the cancer, the previously collected stem cells are reinfused back into the patient’s body. This procedure helps restore the bone marrow’s function and the production of blood cells, allowing the patient to recover from the effects of the cancer treatment. AHSCT can improve survival rates and quality of life for certain patients, making it a vital therapeutic option in oncology.
Examining AHSCT Effectiveness for Progressive Multiple Sclerosis Recent research has scrutinized the efficacy of autologous haematopoietic stem cell transplantation (AHSCT) in individuals suffering from either primary or secondary progressive multiple…